Cancer News: Liver
Regorafenib boosted survival in refractory liver cancer
Patients with refractory liver cancer had a significant reduction in the risk of progression or death when treated with regorafenib, a phase 3 study shows.
Is radiotherapy effective in treating liver cancer?
Treating liver cancer patients with higher doses of radiotherapy increased long-term survival rates that compare favorably with resection, a study showed.
Immunotherapy nivolumab: safe and effective in advanced liver cancer
The immunotherapy nivolumab proved to be safe and highly effective for patients with advanced liver cancer, an early-stage trial suggests.
Higher coffee consumption may protect against liver cancer
A study focused on coffee, alcohol and liver cancer, showing that regular coffee intake could reduce liver cancer risk caused by daily alcohol consumption.
Liver-sparing operation: beneficial approach for liver cancer patients
Removing less of the liver during an operation for liver cancer leads to lower mortality and complication rates in liver cancer patients, according to new study.
Combined therapy benefits liver cancer patients not suitable for surgery
A trial has shown that patients with inoperable advanced hepatocellular carcinoma (HCC) may be able to live significantly longer through a combined therapy.
Diagnosing early liver cancer with new test
Researchers have found a way to make early liver cancer show its true colors. They have developed a test that will help pathologists clearly distinguish early liver cancer cells from nearly identical normal liver cells by giving them a distinctive red-brown hue.
Food toxins related to cervical and liver cancer
Food such as corn tortilla, rice, chili pepper, processed sauces, chicken breast and eggs, are related with cervical and liver cancer in humans, according to scientists.
A variety of cancers destroyed by drug combination therapy
Results from a recent preclinical study have shown that a new drug combination therapy being developed effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
Liver cancer in men could be due to gene deficiency
Hepatocellular carcinoma (the most common type of liver cancer) in males may be developed due to a genetic deficiency.
Liver cancer linked with obesity, alcoholism & hepatitis
Researchers have identified a link, driven by a protein, between liver cancer and obesity, alcoholism & chronic hepatitis.
Large liver tumors can benefit from surgery
Surgery of large liver cancers has been linked to longer overall survival, compared to transarterial chemoembolization (TACE), according to new research.
Potential cholangiocarcinoma treatment via genetics being validated
Personalized treatments for bile duct cancer through genomic sequencing that could help by targeting the Epidermal Growth Factor Receptor (EGFR) are studied.
Liver cancer risk may be reduced by drinking more coffee
A study showed that the risk of developing the most common type of liver cancer (hepatocellular carcinoma, or HCC) is lower for people drinking more coffee.
Liver cancer: new advances in diagnosis, staging and treatment
Data presented at the 2014 International Liver Congress focus on new approaches for improving diagnosis, staging & treatment of hepatocellular carcinoma (HCC).
Survival in advanced liver cancer not prolonged by everolimus
The drug everolimus did not improve overall survival in patients with advanced liver cancer, compared to placebo, according to a published study.